High-Dose Vitamin C Increases Survival in Pancreatic Cancer Patients
A study published in the November issue of Redox Biology reveals that intravenous high-dose vitamin C combined with chemotherapy doubles the survival time of end-stage and metastatic pancreatic cancer patients from eight months to sixteen months.
The study involved 34 patients in the final stages of pancreatic cancer who were randomly divided into two groups. One group received standard chemotherapy, while the other group received chemotherapy along with intravenous infusions of 75 grams of vitamin C three times a week.
According to researchers, the use of vitamin C not only doubled the patients’ survival time but also reduced the side effects of treatment, improving their overall well-being.
End of Message
Feel free to share this content with attribution to The World of Health and Medicine.
